References
- Baker B. S., Griffiths C. E., Lambert S., et al. The effects of cyclosporin A on T lymphocyte and dendritic cell sub‐populations in psoriasis. Br J Dermatol 1987; 116: 503–10
- Baker B. S., Swain A. F., Fry L., et al. Epidermal T lymphocytes and HLA‐DR expression in psoriasis. Br J Dermatol 1984; 110: 555–64
- Bos J. D., Hagenaars C., Das P. K., et al. Predominance of ‘memory’ T cells (CD4+, CDw29+) over ‘naïve’ T cells (CD4+, CD45R+) in both normal and diseased human skin. Arch Dermatol Res 1989; 281: 24–30
- Ferenczi K., Burack L., Pope M., et al. CD69, HLA‐DR and the IL‐2R identify persistently activated T cells in psoriasis vulgaris lesional skin: Blood and skin comparisons by flow cytometry. J Autoimmun 2000; 14: 63–78
- Ellis C. N., Krueger G. G. Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes. N Engl J Med 2001; 345: 248–55
- Cooper J. C., Morgan G., Harding S., et al. Alefacept selectively promotes NK cell‐mediated deletion of CD45R0+ human T cells. Eur J Immunol 2003; 33: 666–75
- Krueger G. G., Papp K. A., Stough D. B., et al. A randomized, double‐blind, placebo‐controlled phase III study evaluating efficacy and tolerability of 2 courses of alefacept in patients with chronic plaque psoriasis. J Am Acad Dermatol 2002; 47: 821–33
- Ellis C. N., Mordin M. M., Adler E. Y. Effects of Alefacept on Health‐Related Quality of Life in Patients with Psoriasis: Results from a randomized, placebo‐controlled phase II trial. Am J Clin Dermatol 2003; 4: 131–9
- Ortonne J. P., Lebwohl M., Em G. C. Alefacept‐induced decreases in circulating blood lymphocyte counts correlate with clinical response in patients with chronic plaque psoriasis. Eur J Dermatol 2003; 13: 117–23
- Goedkoop A. Y., de Rie M. A., Picavet D. I., et al. Alefacept therapy reduces the effector T‐cell population in lesional psoriatic epidermis. Arch Dermatol Res 2004; 295: 465–73
- Krueger J. G., Gilleaudeau P., Kikuchi T., Lee E. Alefacept selectively reduces subpopulations of memory CD4+ and CD8+ T‐cells. J Invest 2002; 119: 759
- Vissers W. H., Berends M., Muys L., et al. The effect of the combination of calcipotriol and betamethasone dipropionate versus both monotherapies on epidermal proliferation, keratinization and T‐cell subsets in chronic plaque psoriasis. Exp Dermatol 2004; 13: 106–12
- Lebwohl M. Combining the new biologic agents with our current psoriasis armamentarium. J Am Acad Dermatol 2003; 49: S118–24
- Kammerer U., Kapp M., Gassel A. M., et al. A new rapid immunohistochemical staining technique using the EnVision antibody complex. J Histochem Cytochem 2001; 49: 623–30